Cell membrane-derived vesicles for delivery of therapeutic agents.
Acta Pharm Sin B
; 11(8): 2096-2113, 2021 Aug.
Article
em En
| MEDLINE
| ID: mdl-34522579
Blood cells; CAR-T, chimeric antigen receptor-engineered T cell; CRISPR, clustered regularly interspaced short palindromic repeats; CXCR4, C-X-C chemokine receptor type 4; Cancer cells; Cell membrane-derived vesicles; DC, dendritic cell; Drug-delivery systems; Immune cells; Manufacturing; Membrane engineering; NF-κB, nuclear factor kappa B; NIR, near infrared; PEG, polyethylene glycol; PLGA, poly(lactic-co-glycolic acid); RBC, red blood cell; Stem cells; TCR, T-cell receptor; TRAIL, tumor necrosis factor-related apoptosis-inducing ligand
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Revista:
Acta Pharm Sin B
Ano de publicação:
2021
Tipo de documento:
Article